Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Parth Overseas is an Indian pharmaceutical chemical company. According to its website, it was established in 1995 and its business revolves around Pharmaceutical Drugs, Fine Chemicals, Pharma Raw Materials, Speciality Intermediates, and Formulation & API Pellets / Premixes. The text also mentions that it exports to over 12 countries and serves 20 pharmaceutical laboratories worldwide. It should be noted that the website content is not an introduction to SaaS or enterprise software, but rather a showcase of pharmaceutical APIs, chemical intermediates, and contract manufacturing services.
Based on the text, its core capabilities include the supply of a diverse range of APIs/pharmaceutical raw materials, specialty intermediates production, manufacturing of various dosage forms (tablets/capsules/injectables/ophthalmic preparations), as well as processing forms like half-dosage formulations, ready to fill, fine pellets, and water dispersible granulation. The company also mentions having a manufacturing unit in the suburbs of Mumbai with an R&D department where scientific personnel engage in new molecule development. In terms of compliance, the text states that the factory is approved by the Indian FDA and plans to apply for US FDA approval in the future. It also mentions an FDA approved WHOGMP plant in Gujarat, India, and a regulatory team capable of preparing DMF/Dossiers in CTD format.
The page does not disclose prices, packages, or an online purchasing process; it only states that customers can inquire about products of interest, and the company will send specifications and quotes. Therefore, its business model is closer to B2B inquiries, custom quotes, and contract manufacturing, rather than subscription-based SaaS.
The scraped text contains no information regarding cloud deployment, self-hosting, account systems, permission management, team collaboration, third-party integrations, API interfaces, developer documentation, data security policies, or free trials. As a result, it cannot be effectively evaluated as enterprise software, nor should SaaS scoring be applied to it.
Pros include a broad product range, along with contract manufacturing, exclusive development, and registration document support. It may hold reference value for API purchasers, pharmaceutical laboratories, and enterprises needing specialty intermediates or formulation premix processing. Cons are that the website information is mostly a static catalog, lacking details on production capacity, certification documents, quality system specifics, delivery lead times, payment methods, and after-sales support.
Access from China cannot be determined from the text and is marked as unknown. If Chinese enterprises need to purchase pharmaceutical APIs or intermediates, they can use this as an overseas supplier lead and compare quality, compliance, delivery, and pricing with domestic API and CDMO/CMO manufacturers, as well as other Indian suppliers. If the goal is to find SaaS/enterprise software, this website is not a suitable alternative.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on parthoverseas.in official site.
parthoverseas.in is an India Health provider. TG4G tracks its product information, an overall rating of 5.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach parthoverseas.in directly.